Susanne Haindl - Publications

T-Cell Engager-Mediated HLA Antibody Depletion before Kidney Transplantation.

Journal: The New England journal of medicine

Published: July 29, 2026

Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension.

Journal: The Lancet regional health. Europe

Published: March 30, 2026

Functional Natural Killer-cell Genetics and Microvascular Inflammation After Kidney Transplantation: An Observational Cohort Study.

Journal: Transplantation

Published: October 15, 2024

A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.

Journal: The New England journal of medicine

Published: May 28, 2024

Natural Killer Cell Presence in Antibody-Mediated Rejection.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: April 30, 2024

Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 16, 2023

Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10.

Journal: Transplantation direct

Published: August 31, 2022

Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Renal Allograft Rejection: Accumulation of Antibody-neutralized Interleukin-6 Without Signs of Proinflammatory Rebound Phenomena.

Journal: Transplantation

Published: August 15, 2022

Levels of donor-derived cell-free DNA and chemokines in BK polyomavirus-associated nephropathy.

Journal: Clinical transplantation

Published: March 10, 2022

Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome.

Journal: Frontiers in immunology

Published: December 05, 2021

Early Estimated Glomerular Filtration Rate Trajectories After Kidney Transplant Biopsy as a Surrogate Endpoint for Graft Survival in Late Antibody-Mediated Rejection.

Journal: Frontiers in medicine

Published: November 17, 2021

Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: June 15, 2021